title: Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations.
abstract: We have determined the prevalence of familial hypercholesterolaemia (FH) in a rural Afrikaner community by means of direct DNA screening for three founder-related Afrikaner low density lipoprotein (LDL) receptor gene mutations. A random sample of 1612 persons, aged 15-64 years, was selected as a subsample of 4583 subjects from an Afrikaner community living in the south-western Cape, South Africa. Participants who had a total serum cholesterol (TC) in the high TC category as defined in the consensus recommendations by the Southern African Heart Foundation, were screened for three founder-related LDL receptor gene mutations, causing FH in 90% of Afrikaners. Of the subsample, 201 participants (12.5%) had TC levels above the 80th percentile. In this group the combined prevalence of the three common Afrikaner LDL receptor gene defects (D206E, FH Afrikaner-1; V408M, FH Afrikaner-2; D154N, FH Afrikaner-3) was calculated as 1: 83. When taking into account the reported background prevalence of other FH gene defects of 1:500 in this community, their overall prevalence of FH was estimated to be 1:72. The significant differences found between the FH patients and other high risk patients with raised cholesterol levels were higher TC and LDL cholesterol levels and lower high density lipoprotein cholesterol levels in FH patients. The treatment status of the molecularly identified FH patients and other hypercholesterolaemic persons suggests that this condition is inadequately diagnosed and poorly managed in this study population. An extrapolation to the entire South African population suggests that there are about 112000 FH patients in the country who are under-diagnosed as a group and therefore not receiving the care that would help to reduce the burden of FH-associated ischaemic heart disease in South Africa.
authors.affiliation: Medical Research Council, Tygerberg, South Africa.
authors.forename: K
authors.initials: K
authors.lastname: Steyn
authors.forename: Y P
authors.initials: YP
authors.lastname: Goldberg
authors.forename: M J
authors.initials: MJ
authors.lastname: Kotze
authors.forename: M
authors.initials: M
authors.lastname: Steyn
authors.forename: A S
authors.initials: AS
authors.lastname: Swanepoel
authors.forename: J M
authors.initials: JM
authors.lastname: Fourie
authors.forename: G A
authors.initials: GA
authors.lastname: Coetzee
authors.forename: D R
authors.initials: DR
authors.lastname: Van der Westhuyzen
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000453:epidemiology* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D017202:Myocardial Ischemia / Q000453:epidemiology / Q000517:prevention & control; D009426:Netherlands / Q000208:ethnology; D015995:Prevalence; D011973:Receptors, LDL / Q000235:genetics*; D012307:Risk Factors; D012424:Rural Population / Q000706:statistics & numerical data; D012727:Sex Characteristics; D013019:South Africa / Q000453:epidemiology; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D011973:Receptors, LDL; D014280:Triglycerides; D002784:Cholesterol